Uscom Ltd
ASX:UCM

Watchlist Manager
Uscom Ltd Logo
Uscom Ltd
ASX:UCM
Watchlist
Price: 0.012 AUD Market Closed
Market Cap: AU$3.1m

Uscom Ltd
Investor Relations

Uscom Ltd. engages in the development, design, manufacture, and marketing of non-invasive cardiovascular and pulmonary medical devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2003-12-10. The firm manages a network of distribution partners across the world for the sale of its equipment to hospitals and other medical care locations. Its geographic segments include Singapore, Australia, China, South East Asia, Europe and the United States. The firm has approximately three practice suites of devices in the field of cardiac, vascular and pulmonary monitoring, including the USCOM 1A, which is an hemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment, USCOM BP+, which is a supra systolic oscillometric Central Blood Pressure monitor that measures blood pressure and blood pressure waveforms only previously available using cardiac catheterization, and the Uscom SpiroSonic spirometers, which is a digital pulmonary testing device.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Robert Allan Phillips AMS, DMU, FASE, FIR, MPhil (Med), Ph.D.(Med)
Founder, Executive Chairman, CEO & Chief Scientist
No Bio Available
Mr. Brett Thomas Crowley B.Com., BCom, C.A., CA, DipLaw
Company Secretary & Non-Executive Director
No Bio Available
Mr. Nicholas Schicht BEng
General Manager
No Bio Available

Contacts

Address
NEW SOUTH WALES
Sydney
L 8 66 Clarence Street
Contacts
+61292474144.0
www.uscom.com.au